Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Tomotherapy Stories

2008-10-15 18:00:24

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Grupo IMO of Madrid, Spain, recently hosted a symposium on the clinical use of the Hi-Art(R) treatment system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Symposium speakers highlighted the Hi-Art system's inherent suitability for stereotactic procedures with respect to dose conformality and homogeneity; presented clinical work on a variety of intra- and extracranial cases; and discussed future...

2008-09-22 18:00:34

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it is developing the world's first mobile radiation therapy solution. The company plans to house its revolutionary Hi-Art(R) treatment system in trailers that would be available for use by TomoTherapy customers during new construction, in advance of system installation, to alleviate temporary backlogs, or as a permanent placement for centers that are unable to expand their facility. The announcement was made today at the 50th annual...

2008-09-18 18:00:50

Compact Particle Acceleration Corporation (CPAC) today announced that it introduced its state-of-the-art compact proton therapy program, featuring a dielectric-wall accelerator (DWA), during the European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting that concluded today in Gothenburg, Sweden. The proton system is currently being co-developed by CPAC and TomoTherapy Incorporated (NASDAQ: TOMO), maker of the Hi-Art(R) treatment system for advanced radiation therapy, and...

2008-09-18 18:00:50

More than 300 members of Europe's radiation oncology community attended a TomoTherapy(SM)-focused symposium on Tuesday, Sept. 16, 2008 in Gothenburg, Sweden. The Advanced Clinical Solutions Symposium was hosted by TomoTherapy Incorporated (NASDAQ: TOMO), maker of the Hi-Art(R) treatment system, and held during the European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting. Four eminent clinical experts, including ESTRO president Prof. Vincent Gregoire, discussed the...

2008-09-18 00:00:30

Thousands of cancer patients in need of proton therapy--a form of radiation therapy without many of the short- and long-term side effects-- can look forward to having a treatment center available in Illinois with the 4-0 approval today by the Illinois Health Facilities Planning Board (IHFPB) of the Proton Therapy Center of Central DuPage Hospital. Construction on the 58,000-square-foot, state-of-the-art proton therapy treatment center in Warrenville's Cantera development will begin...

2008-09-15 09:00:58

Varian Medical Systems, a manufacturer of medical devices and software, has announced that the Ghent University Hospital in Belgium is acquiring the company's RapidArc technology for fast and efficient modulated arc therapy treatments for cancer patients. According to Varian Medical Systems, RapidArc delivers a volumetric intensity-modulated radiation therapy treatment in a single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced...

2008-09-11 18:00:36

SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (the "Company" or "Pharmacyclics") announced today that Christine A. White, M.D., Richard M. Levy Ph.D., Mr. Miles R. Gilburne and Richard A. Miller, M.D. have resigned as members of the Board of Directors of the Company, effective immediately. The remaining members of the Board of Directors, consisting of Mr. Robert W. Duggan and Mr. James L. Knighton, appointed Minesh Mehta, M.D. and Glenn C. Rice, Ph.D. to the...

2008-09-10 18:00:34

TomoTherapy Incorporated (NASDAQ: TOMO) today announced that Azienda Ospedaliero - Universitaria di Modena in Modena, Italy has selected the Hi-Art(R) treatment system for advanced radiation therapy. The leading Italian hospital was able to make this revolutionary technology available to regional cancer patients less than a month after receiving the system. Stefano Cencetti, MD, Executive Director of Azienda Ospedaliero - Universitaria di Modena, explained, "Thanks to the perfect...

2008-09-09 18:00:33

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it has partnered with Vision RT to expand imaging options for Hi-Art(R) treatment system users. The companies will jointly introduce AlignRT(R) 3D imaging technology for the Hi-Art platform at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, Mass., Sept. 21-25, 2008. TomoTherapy will distribute AlignRT(R) for use with both its TomoHelical(TM) and new TomoDirect(TM) delivery modes....

2008-09-04 09:00:49

SUNNYVALE, Calif., Sept. 4 /PRNewswire/ -- Xoft, Inc., developer of the Axxent(R) Electronic Brachytherapy (eBx) System, a proprietary cancer treatment platform that utilizes X-rays to deliver non-radioactive, isotope- free radiation therapy directly to cancer sites, today announced that it will present at the 2008 Citi Investment Research Emerging Medical Technology Conference on Radiation Oncology. Xoft president and CEO, Michael Klein, will present on September 4 at 1:30 pm at the Citi...